Kidney Disease Clinical Trials

Showing 3301-3320 of 3,902 trials

The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup

NCT01680744

To protect kidney function during the transplantation process by inducing mild hypothermia in the deceased organ donor before organs are recovered

Deceased Organ DonorMild HypothermiaRenal Function

University of California, San Francisco370 participantsStarted May 2012

San Francisco, California, United States

COMPLETEDPhase 3

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

NCT01074125

This is a research study for people with high blood phosphorus levels who are on dialysis. This medical condition can cause weakening of the bones and damage other organs. This can lead to many health problems, and sometimes death. Phosphorus is in much of the food we eat, and is helpful to us in small amounts. Patients with kidney failure have trouble getting rid of the phosphorus eaten in food. Dialysis can help remove some of the phosphorus, but often patients must take a phosphate binder like PhosLo®, Renagel®, or Renvela® to bring the blood phosphorus levels back to normal. The purpose of this study is to see if KRX-0502 (ferric citrate) is safe and effective as a phosphate binder.

HyperphosphatemiaEnd-Stage Renal Disease

Keryx Biopharmaceuticals154 participantsStarted May 2010

Westminster, Colorado, United States • Pembroke Pines, Florida, United States • Augusta, Georgia, United States +13 more locations

The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Related Searches

A Study on the Efficacy and Safety of Continuous Renal Replacement Therapy (CVVHDF) Using a Commercial Citrate-containing Replacement Fluid (Prismocitrate 18/0)

Interaction Between Rimonabant and Cyclosporine and Tacrolimus

Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

Biomarkers Correlation With Volemia

Circulating lncRNA and CV Morbidities in CKD and ESRD

Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease

IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.

Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis

Calcineurin Activity in Renal Recipients

Pilot Study for HLA Identical Living Donor Renal Transplant Recipients

Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease (CKD) Patients in Singapore

A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis

Vascular Access Choice and Outcomes in the Elderly and Very Elderly With End Stage Renal Disease in China

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function

Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure